Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "Global Hematological Drugs Market (2023-2028) by Drugs Class, Route of Administration, End Users, and Geography, Competitive Analysis, Impact of Economic Slowdown & Impending Recession with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
According to this report, the global hematological drugs market is estimated to be USD 81.34 Bn in 2023 and is expected to reach USD 127.12 Bn by 2028, exhibiting a robust CAGR of 9.34%.
Market Dynamics:
The Hematological Drugs Market is influenced by various factors that drive, restrain, and offer opportunities and challenges for its growth. The key market dynamics are as follows:
Drivers:
- Rising Prevalence of Blood Disorders: The increasing incidence of blood disorders, such as anemia, thrombosis, and hemophilia, is fueling the demand for hematological drugs worldwide.
- Adaptation of Unhealthy Lifestyle: Unhealthy lifestyle habits, including sedentary behavior and poor dietary choices, are contributing to the rising prevalence of blood disorders, leading to a surge in the demand for hematological drugs.
Restraints:
- High Cost of Immunohematology Devices: The high initial cost associated with immunohematology devices poses a challenge for market growth, particularly in resource-constrained regions.
Opportunities:
- Introduction of Automation in Immunohematology Devices: Advancements in technology have led to the introduction of automated immunohematology devices, which enhance efficiency and accuracy, creating new growth opportunities in the market.
- Rising Number of Innovations and R&D Activities: Increasing research and development activities and innovations in hematological drugs are likely to drive market growth, with the potential for the development of novel therapeutic options.
Challenges:
- Technical and Clinical Limitations of Serologic Immunohematology: Serologic immunohematology has certain technical and clinical limitations that might hinder its adoption and restrict market growth.
Market Segmentations:
The Global Hematological Drugs Market is segmented based on Drugs Class, Route of Administration, End Users, and Geography.
- By Drugs Class, the market is classified into:
- Anticoagulants
- Antiplatelet
- Iron Supplements
- Anti-Thymocyte Globulins
- By Route of Administration, the market is classified into:
- Oral
- Parenteral
- By End Users, the market is classified into:
- Hospitals
- Specialty Clinics
- By Geography, the market is classified into:
- Americas
- Europe
- Middle-East & Africa
- Asia-Pacific
Why buy this report?
The "Global Hematological Drugs Market (2023-2028)" report offers a comprehensive evaluation of the market with in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The report is compiled through extensive primary and secondary research, which includes interviews, surveys, and observations of renowned industry personnel. The report includes an in-depth market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. Additionally, it addresses the impact of COVID-19 and the economic slowdown on the market, along with regulatory scenarios across various geographies. The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.
Report Highlights:
- Comprehensive analysis of the market, including key market dynamics and trends.
- In-depth market segmentation analysis.
- Historical, current, and projected market size based on value and volume.
- Market shares and strategies of key players.
- Recommendations to companies for strengthening their foothold in the market.
Competitive Landscape
- AbbVie Inc.
- Amgen
- Alexion Pharmaceuticals
- Beckman Coulter
- Bristol-Myers Squibb Co.
- Dr. Reddy's Laboratories Ltd.
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline PLC
- Mylan N.V.
- Novartis Ag
- Pfizer Inc.
- Sanofi
- Takeda Pharmaceuticals
- Teva Pharmaceuticals Industries Ltd.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 184 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value (USD) in 2023 | $81.34 Billion |
| Forecasted Market Value (USD) by 2028 | $127.12 Billion |
| Compound Annual Growth Rate | 9.3% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/mlzzor
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
